On Invalid Date, Becton Dickinson & Co (NYSE: BDX) reported Q4 2023 earnings per share (EPS) of $0.97, up 43.27% year over year. Total Becton Dickinson & Co earnings for the quarter were $281.00 million. In the same quarter last year, Becton Dickinson & Co's earnings per share (EPS) was $1.71.
As of Q2 2024, Becton Dickinson & Co's earnings has grown -20.79% year over year. This is 47.95 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 27.17%. Becton Dickinson & Co's earnings in the past year totalled $1.22 billion.
What is BDX's earnings date?
Becton Dickinson & Co's earnings date is Invalid Date. Add BDX to your watchlist to be reminded of BDX's next earnings announcement.
What was BDX's revenue last quarter?
On Invalid Date, Becton Dickinson & Co (NYSE: BDX) reported Q4 2023 revenue of $4.71 billion up 2.62% year over year. In the same quarter last year, Becton Dickinson & Co's revenue was $4.59 billion.
What was BDX's revenue growth in the past year?
As of Q2 2024, Becton Dickinson & Co's revenue has grown 4.02% year over year. This is 3.73 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.75%. Becton Dickinson & Co's revenue in the past year totalled $19.49 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.